Long and colleagues have studies IgM and IgG using a combination of S and N antigens in 363 samples from COVID-19 positive patients and observed a medium IgG- and IgM positive serostatus at day 13 after the symptom onset and a 100% seroconversion for IgG at day 20 [40]. This evidence concerns the gene CD40LG and COVID-19.